ImVitro
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ImVitro - overview
Established
2019
Location
Paris, -, France
Primary Industry
Medical Devices & Equipment
About
Based in France, and founded in 2019 by its CEO Alexandra Boussommier Calleja, ImVitro operates as a life science company that manufactures artificial intelligence (AI) medical devices for in vitro fertilization (IVF) procedures. In December 2022, ImVitro raised USD 2. 5 million in seed funding led by LDV Capital, with participation from Compound Ventures, Fly Ventures, MMC Ventures, and Tiny Super Computer Investment Company. As of December 2022, the company has an office in France and London, UK.
ImVitro provides a saas based platform Embryoly that assists In Vitro Fertilization by analyzing over 30 clinical data points to create a hybrid score that includes the patient’s BMI, uterus receptivity, spermatozoa mobility, and more to improve accuracy and help personalize and standardize results and KPIs. It predicts the likelihood of each embryo leading to a clinical pregnancy. The company plans to use the seed funding to expand to the U. S.
market, develop additional features to its software as well as expand its team.
Current Investors
MMC Ventures, Compound Ventures, LDV Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment, Medical Software, Monitoring & Security Software
Website
www.im-vitro.com
Verticals
Artificial Intelligence, Cloud Computing, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
ImVitro - timeline of key events
ImVitro - financials
| Fiscal Year Ended | Dec 31, 2022 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
ImVitro - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.